Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The DNA replication licensing system

P Thömmes1, J J Blow

  • 1Imperial Cancer Research Fund, Clare Hall Laboratories, South Mimms, Herts.

Cancer Surveys
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

3 tera-basepairs as a fundamental limit for robust DNA replication.

Physical biology·2020
Same author

Quaternary structure of the human Cdt1-Geminin complex regulates DNA replication licensing.

Proceedings of the National Academy of Sciences of the United States of America·2009
Same author

Reconstitution of licensed replication origins on Xenopus sperm nuclei using purified proteins.

BMC biochemistry·2001
Same author

DNA replication: stable driving prevents fatal smashes.

Current biology : CB·2001
Same author

The origin of CDK regulation.

Nature cell biology·2001
Same author

Control of chromosomal DNA replication in the early Xenopus embryo.

The EMBO journal·2001
Same journal

Future directions: bladder cancer.

Cancer surveys·2004
Same journal

Radiotherapy and chemotherapy for invasive bladder cancer.

Cancer surveys·2004
Same journal

The role of surgery in the multimodality treatment of bladder cancer.

Cancer surveys·2004
Same journal

Clonal development of bladder cancer and its relevance to the clinical potential of HLA antigen and TP53 based gene therapy.

Cancer surveys·2004
Same journal

Clinical evaluation of immunotherapy: are there differences between papillary and flat in situ bladder cancer?

Cancer surveys·2004
Same journal

Molecular biological changes in bladder cancer.

Cancer surveys·2004
See all related articles

The Xenopus cell-free system identified a replication licensing factor (RLF) crucial for DNA replication and preventing rereplication. This factor, composed of RLF-B and MCM/P1 proteins, is essential for initiating DNA synthesis each cell cycle.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • The Xenopus cell-free system is a valuable model for studying DNA replication and cell cycle control.
  • Understanding the mechanisms that prevent DNA rereplication is critical for maintaining genomic stability.

Purpose of the Study:

  • To investigate the replication licensing factor (RLF) involved in preventing DNA rereplication.
  • To biochemically purify and characterize the components of RLF.

Main Methods:

  • Utilized the Xenopus cell-free system for in vitro DNA replication studies.
  • Employed protein kinase inhibitors to arrest extracts and develop an in vitro assay.
  • Performed biochemical purification to isolate RLF components.

Related Experiment Videos

Main Results:

  • Identified a replication licensing factor (RLF) that binds chromatin before S-phase and is displaced during replication.
  • RLF comprises RLF-B and RLF-M (MCM/P1 proteins), which are essential for initiating DNA replication.
  • MCM/P1 proteins require RLF-B for chromatin loading, and their activity is regulated by phosphorylation.

Conclusions:

  • The nuclear envelope plays a role in preventing RLF re-binding and ensuring cell cycle progression.
  • The identified licensing mechanism, involving MCM/P1 proteins and RLF-B, is conserved across eukaryotes, similar to yeast prereplicative complexes.